Robotic Nurse Assistant Market Size Worth $1,642.2 Million By 2026

The global robotic nurse assistant market size is expected to reach USD 1,642.2 million by 2026, according to a new report by Grand View Research, Inc. Rising geriatric population and decrease in the nurse-to-patient population are some of the factors contributing to the growth of robotic nurse assistant in the coming years. Rising research funding in healthcare robotics is expected to drive the demand for robotic nurse assistant over the forecast period.

Independence support robots dominated the product type segment with a market share of 42.7% in 2018. Growing geriatric population requiring continuous nursing assistance has increased the demand for independence support robots. On the other hand, daily care & transportation robots segment is expected to witness the fastest CAGR between 2019 to 2026. The ability to automate repetitive tasks with great accuracy is one of the major factors driving the growth of this segment.

Hospitals and clinics dominated the end-use segment in 2018, with a revenue of USD 182.4 million and are expected to remain the largest segment over the forecast period. Senior care facilities segment is anticipated to witness the fastest growth, with a CAGR from 2019 to 2026 owing to the rising need for intensive patient care to the elderly and disabled population.

North America dominated the robotic nurse assistant market with the revenue share of 40.5% in 2018, owing to higher economic capabilities of hospitals and clinics to invest in robotic nurses. This region is anticipated to witness lucrative growth due to its expanding geriatric population, which is directly responsible for the rising demand for robotic nurse assistants. The U.S. dominates the North America market with 87.8% revenue share in 2018. High healthcare expenditure and well-established healthcare infrastructure are some major factors driving the demand for robotic nurse assistant in this region between 2019 to 2026.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/robotic-nurse-assistant-market

Further Key Findings From the Report Suggest:

North America accounted for the largest revenue share 2018, owing to factors such as large geriatric population and rising need to maintain the ratio of nurses to patient’s population
Independent support robots segment dominated the product segment in 2018 owing to rising funding for the development of nurse assisting robots
Hospitals and clinics segment dominated the market with a revenue of USD 182.4 million due to growing adoption of healthcare robots for supporting elderly population
Some of the key market players in this market are Hstar Technologies, Diligent Robotics, Toyota Motor Corporation, RIKEN-SRK, SoftBank Robotics, Panasonic, Fraunhofer IPA, Aethon and others.

Liposuction Surgery Devices Market Size Worth $1.2 Billion By 2026

The global liposuction surgery devices market size is expected to reach USD 1.2 billion by 2026 at a CAGR of 11.7%, according to a new report by Grand View Research, Inc. Increased awareness regarding new cosmetic treatments in the developed economies, such as North America is one of the major driving factors of the liposuction surgery devices. In addition, integration of modern technology and adoption of technologically advanced surgical devices is fueling market growth.

The growing demand for cosmetic surgeries across the globe is another driving factor of this market. Lipoplasty is one of the common cosmetic surgeries witnessed in the United States. Annually, more than 3,00,000 liposuction surgeries are operated with an approximate cost of $2000-3500. High disposable income of consumers is another driving factor for the growth of liposuction surgery in North America. These factors are expected to propel the industry growth.

Suction-assisted lipectomy, power-assisted, ultrasound-assisted, laser-assisted, and RF-assisted are some of the current technologies used in surgeries. Different technologies are used based on the patient’s body characteristics and cosmetic surgeon’s preference. The right use of technology will bring a better outcome to the lipoplasty surgery.

In addition, the rising obesity cases are increasing the demand for liposuction surgery. However, minor complications, such as numbness, swelling, bad bruising, and more associated with targeted surgery is hampering market growth. Nonetheless, increasing research and development in the domain and launch of new technologies are expected to overcome these drawbacks.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/liposuction-surgery-devices-market

The standalone segment accounted held a dominant share of the liposuction surgery devices market in 2018 in terms of revenue. Easy usage, convenience, and growing innovations in the devices are expected to propel the segment growth in the coming years
Growing number of qualified & trained cosmetic surgeons, and practitioners are encouraging patients to opt for such cosmetic surgeries.
Laser-assisted liposuction (LAL) segment held a significant share of the market due to the increasing adoption owing to its benefits, such as a quick and effective way of removing body fat.
Key players of the market include Solta Medical, Cynosure Inc., Sciton Inc., Wells Johnson Co, Invasix Ltd, Zeltiq aesthetics Inc, Alma Lasers, Bausch Health, Genesis Biosystems, Inc., Hologic Inc., and YOLO Medical Inc.

Smoking Cessation & Nicotine De-Addiction Market Worth $21.8 Billion By 2024

The global smoking cessation and nicotine de-addiction market is expected to reach over USD 21.8 billion by 2024 according to a new report by Grand View Research, Inc.

The base of population addicted to smoking is rapidly increasing across the globe. This population subset majorly includes teenagers and the working population. Smoking-related mortality is very high. The increasing desire to quit smoking and the numerous health complications associated with smoking serve as strong incentives for companies to introduce novel smoking cessation products, such as Revolymer, which has introduced the next generation nicotine gums to help smokers quit smoking. The launch of these improved and innovative nicotine replacement therapy products is to serve as a high impact rendering driver for the growth of the smoking cessation and nicotine de-addiction market.

The growing incidence of target diseases such as chronic obstructive pulmonary disease (COPD), asthma, cardiac diseases, and lung cancer, and the increasing awareness pertaining to the hazardous side-effects of smoking are the factors expected to promote market expansion. Educational institutions remain active in organizing various campaigns and programs to spread information about the harmful effects and consequences of smoking so as to increase young population awareness.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/smoking-cessation-and-nicotine-de-addiction-products-market

Further key findings from the study suggest:

Nicotine Replacement Therapy (NRT) dominated the smoking cessation and de-nicotine addiction product market in 2015. Majorly used NRT products include nicotine chewing gums and the transdermal patches. Increased availability and the introduction of the ingestible nicotine products with different flavors are the factors responsible for its large market share.
The e-cigarette segment is anticipated to grow at a CAGR of19.0% over the forecast period. The major factors responsible for the growth of the E-cigarette market include the introduction of second and third generation e-cigarettes, the availability of various flavored products, the presence of numerous vendors operating and selling e-cigarettes under different brand names.
North America held a large market share of over 35.0% in 2015 owing to the high awareness levels of nicotine de-addiction products with around 90% of the U.S. population were identified as aware of e-cigarettes in 2015
Asia Pacific is the fastest growing market. The registration of nicotine de-addiction products and e-cigarettes as well as the strengthening of the company distribution channels in countries, such as China, India, and Australia are expected to support the growth over the forecast period
Some key players of this market are Pfizer, Inc., Cipla Ltd., Novartis International AG, GlaxoSmithKline plc, Takeda pharmaceutical Company Ltd., McNeil AB, Revolymer plc, Imperial Tobacco Ltd., and VMR products, LLC
The market players are making slow but steady progress in the e-cigarette market by focusing on the development, commercialization, and distribution of the FDA approved nicotine products. For instance, in 2014, Victory Electronic Cigarettes Corporation acquired Ten Motives Ltd. with an aim to expand their distribution channels and attain wider market coverage.

Gynecological Devices Market Size Worth $17.55 Billion By 2026

The global gynecological devices market size is projected to reach USD billion 17.55 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 8.8% during the forecast period. Growing female population, increasing awareness levels pertaining to benefits of early diagnosis, and available treatments are anticipated to stoke the growth of the market.

Rising prevalence of sexually transmitted diseases is translating into greater demand for gynecological treatments. Prevalence of these diseases was observed to be higher in people aged between 15-24 years. For instance, according to the Centre for Disease Control and Prevention (CDC), around 45.0% of the patients in the U.S. with Chlamydia were aged between 20 and 24 years.

Moreover, rising adoption of gynecological procedures is estimated to boost usage rates over the forecast period. The percent of C-section deliveries was 32.2% as compared to number of vaginal deliveries. Upswing in the number of these procedures owing to growing population, increasing awareness, and rising disposable income is expected to drive the gynecological devices market.

Early disease detection is imperative in devising treatment schedules. Pertinent government and regulatory agencies in congruency with aforementioned factors are now focusing majorly on improving patient awareness levels.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/gynecological-device-market

Further Key Findings from the Report Suggest:

Surgical devices accounted for the largest market share in 2018. High cost of surgical devices and recurring purchase of disposable products are contributing to the growth of the segment
Endoscopy devices were the leading revenue contributing sub-segment in 2018. Availability of user-friendly, portable, and affordable products is likely to escalate the growth of the segment during the forecast period
North America was the largest regional market in 2018. Presence of a well-established healthcare infrastructure, high adoption rate of advanced technology, and large number of skilled professionals are supplementing the growth of the market in the region
Asia Pacific is poised to register a significant CAGR during the forecast period. Rapid surge in procedure volumes, as a result of booming medical tourism industry, has been augmenting the regional market
Some of the key players in the gynecological devices market are Ethicon, Inc.; Karl StorzGmbH & Co. KG; Hologic, Inc.; Boston Scientific Corporation; Stryker Corporation; Olympus Corporation; Richard Wolf GmbH; Medtronic Plc; and CooperSurgical, Inc.

Healthcare Business Intelligence Market Worth $10.64 Billion By 2025

The global healthcare business intelligence market size is expected to reach USD 10.64 billion by 2025, registering a CAGR of 12.8% during the forecast period, according to a new report by Grand View Research, Inc. Increase in adoption of data-driven decision making, emergence of cloud based business intelligence (BI) solutions for healthcare industry, increased focus to reduce spending, and emergence of mobile-based healthcare BI solutions are the key factors contributing to the growth. Growing requirement of business intelligence tools to reduce costs for operational performance, claims, and clinical analysis is another major factor positively impacting the market.

Factors, such as the constantly increasing volume of digital information and data sources, complexity of data generated in healthcare organizations, coupled with growing need for the advanced business intelligence solutions to support decision-making are boosting the demand for business intelligence solutions and services. The massive amounts of unstructured and structured data generated by medical organizations and institutions is critical to manage, thus there is huge requirement for advanced healthcare BI software by hospitals and other healthcare organizations.

In order to gain insights about patient care and satisfaction, clinical operations, labor distribution, physician practices, and administration and management; hospitals and other healthcare facilities require data visualization and predictive modeling tools, which in turn is increasing demand for healthcare business intelligence software among these end users.

Increasing adoption of cloud-based healthcare BI software solutions coupled with high dependency of healthcare on digital technology to operate functions of a complex healthcare system is further boosting the adoption of BI software over the past years. For instance, KenSci Clinical Analytics, a platform designed by Microsoft to predict clinical and operational risk involved in a healthcare facility to improve health outcomes and reduce operational costs.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/healthcare-business-intelligence-market

Further key findings from the study suggest:

Software emerged as the largest product segment with a revenue share of 68.4% in 2018
Cloud-based mode of delivery accounted for the largest revenue share in 2018 and is expected to register the fastest CAGR over the forecast period
Healthcare payers emerged as the leading end use segment, however healthcare providers end use segment is expected to grow at a significant CAGR over the forecast period
North America accounted for the largest share of the healthcare business intelligence market due to increased implementation of healthcare BI solutions and services by the providers to offer enhanced patient care and reduced healthcare expenses
Market players, such Oracle Corporation; SAP; Microsoft; Salesforce; Tableau Software; TIBCO Software Inc.; Sisense Inc.; and Looker Data Sciences, Inc. are focused on increasing collaboration with powerful analytics platform providers to gain competitive edge in the market

Oil Free Air Compressors Market Size Worth $15.56 Billion By 2025

The global oil free air compressors market size is expected to reach USD 15.56 billion by 2025, registering a CAGR of 4.8% over the forecast period, according to a study conducted by Grand View Research, Inc. Low maintenance costs, retrofitting of existing systems, efficient operation at lower costs, and rising adoption of variable-speed compressors are some of the key factors driving the market over the forecast period. The products find application in several industries, such as petroleum, electrical power, chemical, and manufacturing. A gradual shift from the traditional manufacturing techniques to economical methods is a major trend in these industries, which helps boost demand for such compressors for optimal energy distribution purposes.

For instance, the government of China has announced strict regulations for environment fortification, which have ultimately increased the demand for energy-efficient products in the country. Oil-free products provide reliability and ease of operation owing to enhanced product performance. Therefore, they are widely used in the construction and mining activities. High transport mobility offered by these products is also projected to spur their demand across several end-use industries, such as oil & gas. Furthermore, involvement of less degradable parts coupled with low maintenance costs will fuel the global demand over the forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/oil-free-air-compressors-market

The portable compressors captured the major market share in 2018 and will maintain the dominance in future on account of their high durability and light weight
Centrifugal products are expected to witness a rapid growth over the forecast period due to their ability to reduce carbon footprint by ensuring clean and uninterrupted air supply
Increasing adoption of compressors with a 2 to 55 kW power rating in the end-use industries is a key factor that positively affecting the growth of the segment over the forecast period
Manufacturing segment held more than 30% of the global share in 2018. However, the home appliances segment is anticipated to register the highest CAGR owing to higher product demand
Asia Pacific is expected to emerge as the largest and fastest-growing segment over the forecast period due to rising need to increase the power generation capacities
Key companies in the global oil free air compressors market include Gardner Denver, Atlas Copco, Ingersoll-Rand PLC, General Electric, and Bauer Group. Most of them are focusing on developing low-maintenance and eco-friendly products to maintain their industry position

Blood Culture Test Market Worth $7.3 Billion by 2026

The global blood culture test market size is expected to reach USD 7.3 billion, at a CAGR of 9.1% by 2026, according to a new report by Grand View Research, Inc. Increasing prevalence of bloodstream infections and infectious diseases is the most significant factor anticipated to propel the growth. Rising demand for advanced diagnostic techniques for the diagnosis of infectious diseases, such as sepsis, is projected to drive the growth. Thus, many manufacturing companies have begun focusing on development of advanced diagnostic instruments and consumables. For instance, Cepheid offers Xpert MRSA/SA assay that aids in accurate detection of SA and MRSA in positive blood culture specimens in about an hour.

Introduction of various government initiatives pertaining to the prevention and control of infections is likely to propel the demand for blood culture tests. According to the Centers for Disease Control and Prevention (CDC), there was 46% decrease in central line-associated bloodstream infections in U.S. between 2008 and 2013, owing to the efforts taken by the U.S. government for the prevention of Hospital-acquired Infections (HAIs).

Click the link below:
https://www.grandviewresearch.com/industry-analysis/blood-culture-tests-market

Further key findings from the report suggest:

Conventional blood culture technique was the largest revenue-grossing segment in 2018 owing to increased applications of this method in hospitals, independent clinical laboratories, and pathology laboratories
In product segment, consumables accounted for the largest market share in terms of revenue in 2018, due the product applications in diagnostics and research, with repetitive purchase, such as blood culture media, assay, kits, and reagents, adding to the revenue
Automated blood culture systems is the fastest growing segment owing to the advantages of automation, such as low chances of error and faster result generation
Molecular technology is projected to expand at the highest CAGR over the forecast period, due to rising demand for advanced products by hospitals and laboratories for diagnosis of infectious diseases
Bacterial infections accounted for the largest revenue share in 2018, due to the fact that they are the most common cause for infection in the blood
Reference laboratories is projected to expand at the highest CAGR during the study period, because there is an increase in outsourcing of blood tests by hospitals to reference laboratories
North America accounted for the largest revenue share of the blood culture test market in 2018, due to the presence of well-developed healthcare infrastructure in this region
Asia Pacific is anticipated to register the highest CAGR during the forecast period owing to increased focus of government on the prevention of infectious diseases
Few key players include Becton, Dickinson and Company; bioMérieux SA; Thermo Fisher Scientific, Inc.; Danaher Corporation; Luminex Corporation; Roche; Bruker Corporation; and Abbott Laboratories.

Vascular Grafts Market Size Worth $3.30 Billion By 2026

The global vascular grafts market size is projected to reach at USD 3.30 billion by 2026 expanding at a CAGR of 6.4%, according to a report by Grand View Research, Inc. Endovascular stent grafts dominated the market in 2018 and is expected to be the second fastest-growing segment over the forecast period. Increasing prevalence of cardiovascular aneurysms is the leading cause of rise in demand for endovascular stent grafts. Low levels of physical activity, sedentary lifestyle, and substance abuse are some of the key factors leading to the high prevalence of renal and Cardiac Diseases (CVDs) globally. The impact of these factors is especially high in developed economies, such as North America and Europe. However, it is expected to shift towards emerging regions, such as Asia Pacific and Latin America, owing to changing demographics.

Key factors attributed to higher impact in these countries are increasing prevalence of aforementioned diseases in geriatric population, rising disposable income, and changing lifestyle patterns. Polytetrafluoroethylene (PTFE) raw material segment led the global market in 2018 with a revenue of USD 710.3 million. The segment is anticipated to expand at the fastest CAGR over the forecast period on account of PTFE graft’s advantages, such as protection against delamination and minimal blood loss. Asia Pacific is expected to be the fastest-growing market with a CAGR of 7.5% over the forecast period due to increasing public and private healthcare expenditure and availability of healthcare insurance across urban and rural centers.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/vascular-graft-market

Further key findings from the study suggest:

Endovascular stent grafts led the market in 2018 as a result of increased prevalence of cardiac aneurysms caused due to sedentary lifestyle and other occupational factors
PTFE grafts led the raw materials segment in 2018 owing to their advantages, such as minimal blood loss and maximum protection against delamination
Moreover, technological advancements in PTFE-based products is anticipated to drive the segment further
North America was the dominant regional market with a revenue of USD 620.9 million owing to high prevalence of CVDs and kidney diseases
The region is projected to maintain the dominance in future due to the presence of advanced healthcare facilities and reimbursement policies
Some of the key companies in this market include Medtronic, plc; LeMaitre Vascular Inc.; Terumo Corp.; Getinge AB; W.L. Gore and Associates, Inc.; and Cook Medical, Inc.
These companies focus on technological innovations, new product launches, and regional expansion to gain a competitive edge

Aesthetic Medicine Market Worth $103.4 Billion By 2026

The global aesthetic medicine market size is expected to reach USD 103.4 billion by 2026, exhibiting a CAGR of 8.9% during the forecast period, according to a new report by Grand View Research, Inc. Some key market drivers are rise in aging population, disposable income, and awareness about the efficacy of aesthetic treatments.

People aged between 25 and 65 years have prominent aging signs, such as wrinkles, fine lines, and dark spots. Rise in geriatric population is likely to boost the demand for aesthetic medicine due to significant rise in the number of target consumers. Moreover, the need for improved aesthetics in the working class population is likely to drive the demand over the forecast period. Improving employment rate, especially in the emerging markets, is anticipated to drive the demand for aesthetic medicine over the forecast period.

However, the presence of stringent regulatory framework to ensure product safety and efficacy is one of the primary factors limiting growth of the global aesthetic medicine market. Lack of skilled professionals required to perform surgical and minimally invasive procedures coupled with the growing overall treatment cost, is expected to hinder the market growth in the forthcoming years.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/medical-aesthetics-market

Further key findings from the report suggest:

Non-invasive procedures segment is expected to maintain its dominance throughout the forecast period. Growing preference for minimally or non-invasive cosmetic surgeries over invasive cosmetic surgeries attributed to various factors, such as lower costs, minimal trauma and incision, faster recovery, and low risk of complications is anticipated to fuel the segment growth
Botox injections, chemical peels, and soft tissue fillers are some of the most frequently performed non-invasive procedures to address some common issues, such as wrinkles, pigmentation, vascular conditions, loss of skin tone, and dull skin
Breast augmentation and nose reshaping in the invasive procedures segment are anticipated to witness rapid growth in the forthcoming years owing to availability of a rising number of advanced technologies and skilled surgeons
Asia Pacific is anticipated to witness rapid growth over the forecast period, owing to the presence of a large target population pool between 25 to 65 years in China and India and improving standards of living in the region
Some of the key players operating in the global market include Allergan, Inc.; Alma Laser; Cynosure; Galderma S.A.; Lumenis; Johnson and Johnson; Solta Medical, Inc.; and Syneron Medical Ltd.

Agriculture Equipment Market Size Worth $244.2 Billion By 2025

The global agriculture equipment market size is expected to reach USD 244.2 billion by 2025, expanding at a CAGR of 8.9% from 2019 to 2025, according to a study conducted by Grand View Research, Inc. Rising population has escalated demand for food and has pressurized the agriculture sector to be increasingly efficient and productive. Additionally, increased mechanization in the agriculture sector, rise in demand for agricultural products, and need for profitability and operational efficiency are some of the factors anticipated to drive the agricultural machinery market demand over the forecast period.

Rise in adoption of technology-driven equipment and machinery such as robotics is also anticipated to drive the farm machinery market demand over the forecast years. Farmers in developed regions are adopting modern technologies such as drones, moisture sensors, GPS enabled devices, self-driving tractors, smart irrigation, and terrain contour mapping to increase farm yield and address soaring food demand. Such technological advancements are fuelling the espousal of farm equipment across the globe.

The farm machinery market is also estimated to be driven by increasing sales in developing nations such as India, China, and Brazil, as these countries continue to mechanize their agricultural sectors. Furthermore, strong economic growth and population expansion are expected to impose pressure on the agriculture sectors to be more competent, thus increasing sales.On the down side, high cost of agricultural machinery and financial crisis faced by farmers are some of the major challenges hindering market growth.

The agriculture equipment market is highly competitive and fragmented owing to the presence of few prominent players, along with several medium- and small-scale players accounting for the market share. The key players in the market include John Deere, AGCO, Mahindra & Mahindra, CNH Industrial N.V., Iseki & Co., Ltd., and Kubota.

Several leading vendors are investing in R&D in order to develop innovative equipment and maintain a strong foothold in the market. For instance, in April 2017, Mahindra & Mahindra Limited launched its 24hp 4WD small tractor. It has been available in the Indian market since April 2017. The tractor caters to row cropping and horticulture applications, is capable of lifting up to 750 kg, and is equipped with automatic depth & draft control (ADDC) features.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/agriculture-equipment-market

The global agricultural equipment market is expected to register a CAGR of 8.9% from 2019 to 2025, due to technological advancements in agriculture automation and robotics as well as ever-increasing population
Growing number of government initiatives in developing countries, especially China and India, to enhance agricultural productivity is expected to further spur sale of farm equipment over the forecast period
By product, the tractors segment held the dominant share of over 25.0% in 2018, which is accredited to the fact that farmers are increasingly preferring tractors to increase production and restrict dependency on farm labor
On the basis of application, the harvesting and threshing segment is anticipated to witness significant growth over the forecast period and is expected to exceed a CAGR of 10.0% from 2019 to 2025
The Asia Pacific market is projected to expand at a CAGR of over 9.0%, owing to its existing and improving infrastructure levels, alternative sales channels, and government support
Key players in the market include John Deere, AGCO, Mahindra & Mahindra, CNH Industrial N.V., Iseki & Co., Ltd., and Kubota.